FR2661831B1 - Formules pharmaceutiques pour le traitement des maladies vasculaires peripheriques. - Google Patents

Formules pharmaceutiques pour le traitement des maladies vasculaires peripheriques.

Info

Publication number
FR2661831B1
FR2661831B1 FR9105519A FR9105519A FR2661831B1 FR 2661831 B1 FR2661831 B1 FR 2661831B1 FR 9105519 A FR9105519 A FR 9105519A FR 9105519 A FR9105519 A FR 9105519A FR 2661831 B1 FR2661831 B1 FR 2661831B1
Authority
FR
France
Prior art keywords
treatment
peripheral vascular
vascular diseases
pharmaceutical formulas
formulas
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9105519A
Other languages
English (en)
Other versions
FR2661831A1 (fr
Inventor
Roberto Vescovini
Jose Magistretti Maria
Romano Vitali
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IDB Holding SpA
Original Assignee
IDB Holding SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IDB Holding SpA filed Critical IDB Holding SpA
Publication of FR2661831A1 publication Critical patent/FR2661831A1/fr
Application granted granted Critical
Publication of FR2661831B1 publication Critical patent/FR2661831B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
FR9105519A 1990-05-09 1991-05-06 Formules pharmaceutiques pour le traitement des maladies vasculaires peripheriques. Expired - Fee Related FR2661831B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909010389A GB9010389D0 (en) 1990-05-09 1990-05-09 Pharmaceutical formulations for the treatment of peripheral vascular diseases

Publications (2)

Publication Number Publication Date
FR2661831A1 FR2661831A1 (fr) 1991-11-15
FR2661831B1 true FR2661831B1 (fr) 1995-04-28

Family

ID=10675691

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9105519A Expired - Fee Related FR2661831B1 (fr) 1990-05-09 1991-05-06 Formules pharmaceutiques pour le traitement des maladies vasculaires peripheriques.

Country Status (5)

Country Link
CH (1) CH682454A5 (fr)
FR (1) FR2661831B1 (fr)
GB (2) GB9010389D0 (fr)
HK (1) HK1004889A1 (fr)
IT (1) IT1257884B (fr)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2108993A1 (en) * 1970-10-28 1972-05-26 Forschag Vincamine alkaloid fraction - with sedative and vasoregulating effect
FR2255885B1 (fr) * 1973-12-28 1977-09-09 Centre Etd Ind Pharma
FR2255890B1 (fr) * 1973-12-28 1978-01-13 Centre Etd Ind Pharma
IL60613A (en) * 1979-08-16 1983-12-30 Richter Gedeon Vegyeszet Dermatological compositions applicable directly to the skin comprising an eburnamenine derivative and process for their preparation
US4511557A (en) * 1981-08-24 1985-04-16 Gauri Kailash Kumar Pharmaceutical composition
US4612194A (en) * 1984-02-15 1986-09-16 Roshdy Ismail Anti-rheumatic agents and their use
EP0158090B1 (fr) * 1984-03-07 1990-08-29 Roshdy Dr. Ismail Médicament pour le traitement et la protection de la peau
EP0266968A3 (fr) * 1986-11-03 1988-08-24 Gérard G. Cohen Onguent gélifié contenant un agent vasodilatateur

Also Published As

Publication number Publication date
GB9010389D0 (en) 1990-06-27
GB9109887D0 (en) 1991-07-03
HK1004889A1 (en) 1998-12-11
GB2243779B (en) 1994-06-15
IT1257884B (it) 1996-02-16
FR2661831A1 (fr) 1991-11-15
ITMI911206A1 (it) 1992-11-03
GB2243779A (en) 1991-11-13
ITMI911206A0 (it) 1991-05-03
CH682454A5 (fr) 1993-09-30

Similar Documents

Publication Publication Date Title
ATE252901T1 (de) Arzneimittel zur behandlung von entzündlichen herzkrankheiten
NL194748B (nl) Osmotische doseringsvorm voor behandeling van cardiovasculaire ziekten.
FR2698780B1 (fr) Catheter pour le traitement d'un tissu pathologique.
BE876157Q (fr) Medicament pour le traitement de l'acne
ATE201992T1 (de) Carbostyrilderivat zur behandlung von ophthalmologischen erkrankungen
IT8322855A0 (it) Composizione farmaceutica per la cura delle arteriopatie periferiche.
FR2717080B1 (fr) Utilisation de l'éliprodil et de ses énantiomères pour la préparation de médicaments utiles dans le traitement des neuropathies périphériques et des maladies neurodégénératives centrales.
NL187299C (nl) Gevormde farmaceutische doseringseenheid voor het behandelen van hart- en vaatziekten.
BE887639A (fr) Compositions pharmaceutiques pour le traitement de l'hyperplasie prostatique benigne
NO913117L (no) Fremgangsmaate for behandling av benoedeleggende sykdommer.
BE885291A (fr) Compositions pharmaceutiques pour le traitement des dysfonctionnements cardiaques
FR2658419B1 (fr) Medicament pour le traitement de la dermatite.
FR2718024B1 (fr) Médicament et composition pharmaceutique pour le traitement de l'inflammation.
FR2759906B1 (fr) Utilisation de milnacipran et de ses derives pour la preparation d'un medicament destine au traitement de certaines maladies psychiatriques
FR2661831B1 (fr) Formules pharmaceutiques pour le traitement des maladies vasculaires peripheriques.
FR2600256B1 (fr) Medicament et composition medicamenteuse pour le traitement des tumeurs ainsi que pour le traitement des maladies infectieuses dues aux virus
FR2774289B1 (fr) Medicament pour le traitement des dereglements de l'apoptose
FR2296415A1 (fr) Preparations pharmaceutiques pour le traitement des troubles de la circulation
FR2691064B3 (fr) Nouveau medicament pour le traitement de l'arythmie.
FR2673105B1 (fr) Nouvelles compositions pharmaceutiques, notamment pour le traitement des colopathies fonctionnelles, et procedes de preparation de compositions et de medicaments, notamment pour le traitement de ces affections.
RO86562A2 (fr) Composition vegetale medicamenteuse pour le traitement des affectionsbiliares
BE892339A (fr) Agents pour le traitement d'affections cardiaques coronariennes
BE892781A (fr) Nouvelles compositions pharmaceutiques pour le traitement du diabete
DE69125969D1 (de) Arzneimittel zur Behandlung zentraler neuro-degenerativer Erkrankungen
FR2648042B1 (fr) Utilisation de phenylethanolaminotetralines pour la preparation de medicaments pour le traitement des affections oculaires

Legal Events

Date Code Title Description
ST Notification of lapse